The next chapter for group B meningococcal vaccines
The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...
Prif Awduron: | Wang, N, Pollard, A |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Taylor and Francis
2017
|
Eitemau Tebyg
-
Group B meningococcal vaccine science and policy
gan: Drysdale, SB, et al.
Cyhoeddwyd: (2015) -
Group B meningococcal vaccine: Recommendations for UK use
gan: Pollard, A, et al.
Cyhoeddwyd: (2014) -
Group B meningococcal vaccine: recommendations for UK use.
gan: Pollard, A, et al.
Cyhoeddwyd: (2014) -
Four component meningococcal capsular Group B vaccine in preterm infants.
gan: Sadarangani, M, et al.
Cyhoeddwyd: (2017) -
Meningococcal vaccines.
gan: Rüggeberg, J, et al.
Cyhoeddwyd: (2004)